top of page
Testosterone prescribing
Prescribing advice
Oral estrogens, especially conjugated estrogens can reduce the effectiveness of testosterone by increasing the SHBG levels. Consider switching women with HSDD from oral to transdermal estrogens can be beneficial. Testosterone is aromatised (converted) to estradiol
Side effects or adverse effects are uncommon as long as levels are kept within the female physiological range
1.Monitoring
Baseline total testosterone level and repeat 3 months then yearly
2.Application
Clean dry skin (lower abdomen/upper thighs) and allow to dry before dressing. Skin contact with partners or children should be avoided until dry and hands should be washed immediately after application. The area of application should not be washed for 2-3 hours after application.
3.Products
Testosterone does not have a licence in the UK Document in the patient notes
1. Indication
2. That is off licence
Testim gel [Endo Ventures Ltd] 1% testosterone gel in 5ml tubes: Starting dose 0.5ml (5mg) per day makingeach tube last for 10 days
Tostran [Kyowa Kirin Ltd] (2% testosterone gel in a canister containing 60g ) : Starting dose 1 pump of 0.5g = 10mg on alternate days – each canister should last 240 days
Testogel [Besins Healthcare UK] (2.5g sachets containing 40.5mg testosterone): Starting dose 1/8 of a sachet/day = approx. 5mg/day i.e. each sachet should last 8 days. (new formulation)
Testogel [Besins Healthcare UK] (16.2mg/g per pump) A quarter of a pump daily or half a pump on alternative days. Each container should last 8 months
Androfemme has licence for use in women in Australia- not available on NHS
bottom of page